Neoadjuvant chemotherapy for bladder cancer
Neoadjuvant chemotherapy for bladder cancer
复制标题
DOI：
10.1016/s1078-1439(03)00148-0
复制
发表时间：
2003-11-01
影响因子：
2.7
通讯作者：
Grossman, HB
中科院分区：
文献类型：
--
作者：
Millikan, R;Siefker-Radtke, A;Grossman, HB
虽然现在很明显，化疗可以改善一些肌肉浸润性膀胱癌患者的预后，但这种非常不同的疾病的选择标准还缺乏。作者呼吁建立基于生物学(与解剖学相反)的分期系统，并敦促围手术期化疗应与具有治疗意图的标准组合进行。(C)2003 Elsevier Inc.保留所有权利。
While it is now clear that chemotherapy can contribute to improved outcome for some patients with muscle invasive bladder cancer, selection criteria for this very heterogenous disease are lacking. The authors make an appeal for a biologically (in contrast to anatomically) based staging system, and urge that perioperative chemotherapy be given with standard combinations with curative intent. (C) 2003 Elsevier Inc. All rights reserved.